RecruitingNot ApplicableNCT04550845

Understanding of Genetics by Men at Risk for Prostate Cancer

Sponsor

Mayo Clinic

Enrollment

90 participants

Start Date

May 1, 2023

Study Type

INTERVENTIONAL

Conditions

Prostate Cancer

Summary

With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.

Eligibility

Sex: MALEMin Age: 40 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This study explores how African-American and White men in rural and urban areas understand genetic testing related to prostate cancer risk. Researchers are developing a video-based educational tool to help men better grasp what genetic information means for their health. **You may be eligible if...** - You are an African-American or White man - You are between 40 and 95 years old - You live in a rural or urban area - You speak English - You are willing to provide consent and participate **You may NOT be eligible if...** - You are a woman (women may participate in an advisory role only) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFocus group analyses

Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14 for analysis.

Locations(3)

Mayo Clinic

Phoenix, Arizona, United States

Mayo Clinic in Florida

Jacksonville, Florida, United States

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04550845

Related Trials

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

NCT0733644618 locations

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

NCT0700515433 locations

DESTINY-PANTUMOUR04

NCT0712400017 locations

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

NCT068073593 locations

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

NCT046926751 location